Please try another search
By Miranda Murray and Ludwig Burger (Reuters) -Swiss contract drug manufacturer Lonza said on Wednesday it would buy one of the world's largest manufacturing sites for biologic drugs in California...
ZURICH (Reuters) -Roche is cutting 345 jobs, Swiss website Muula reported, as the drugs company responds to lower profit posted for 2023 and a more cautious outlook for the year ahead. The jobs will...
By Maggie Fick and Ludwig Burger LONDON/FRANKFURT (Reuters) -Roche shares fell more than 4% on Thursday as the market expressed disappointed with the company's more modest than expected 2024 outlook....
By Ludwig Burger (Reuters) -Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant...
Quiver Quantitative - Swiss pharmaceutical giant Roche (ROG) has marked a significant strategic shift by acquiring Carmot Therapeutics (CRMO), an obesity drug developer, for an upfront payment of $2.7...
By Scott Kanowsky Investing.com -- Roche Holding AG Participation (SIX:ROG) says two long-awaited late-stage studies showed that its Alzheimer's disease treatment failed to stem a slide in the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review